Couples' QOL in Metastatic Breast Cancer
Launched by FOX CHASE CANCER CENTER · Dec 1, 2022
Trial Information
Current as of February 05, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Couples' QOL in Metastatic Breast Cancer," is focused on understanding and improving the sexual quality of life for women diagnosed with metastatic breast cancer and their partners. The study aims to adapt a special program designed to help couples deal with the challenges related to intimacy and sexual health that can arise when one partner is living with advanced cancer.
To be eligible for this trial, women must be at least 18 years old, have been diagnosed with stage IV breast cancer, and live with a partner or spouse for at least six months. Both partners should also be able to communicate in English and have reliable phone access. Participants can expect to engage in discussions and activities that address their concerns about sexual intimacy, which may help strengthen their relationship during this challenging time. It's important to note that the trial is currently recruiting participants, and individuals with certain medical conditions or undergoing specific therapies may not be eligible.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient is female
- • Patient is at least 18 years old
- • Patient has a diagnosis of metastatic (stage IV) breast cancer
- • Patient has a partner or spouse who is at least 18 years old
- • Patient lives with a romantic partner (same or opposite sex) for at least 6 months
- • Patient scores 3 or above on Patient Care Monitor sexual concerns item (range: 0-10)
- Exclusion Criteria:
- • Patient or partner is not able to speak and read English
- • Patient or partner has a hearing impairment
- • Patient or partner medically unable to participate as judged by physician/in medical record or by self-report
- • Patient and partner do not have reliable telephone access
- • Patient has overt cognitive dysfunction or psychiatric disturbance such as suicidal ideation or severe mental illness, as observed or judged by the researcher, physician or referring source, or self-report
- • Patient past or current history of any cancer other than non-melanoma skin cancer or breast cancer
- • Patient is currently participating in couple/marital therapy
- • Patient is currently pregnant
About Fox Chase Cancer Center
Fox Chase Cancer Center is a leading academic research institution dedicated to advancing cancer treatment and prevention through innovative clinical trials and cutting-edge research. As a National Cancer Institute-designated Comprehensive Cancer Center, it combines a multidisciplinary approach with a commitment to patient-centered care, fostering collaboration among experts in oncology, surgery, radiation therapy, and supportive care. Fox Chase is renowned for its pioneering contributions to cancer research, translating discoveries into effective therapies and improving patient outcomes, while also prioritizing education and community outreach to enhance public awareness of cancer prevention and treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials